iVOW, Inc. Comments on Center for Medicare & Medicaid Services' National Coverage Determination for Bariatric Surgery.

SAN DIEGO -- iVOW, Inc. (NASDAQ: IVOW), a provider of disease management services for the treatment of chronic and morbid obesity, today commented on the final National Coverage Determination decision issued by the Center for Medicare and Medicaid Services (CMS) which states bariatric surgery will be covered for all Medicare beneficiaries.

The memorandum, issued February 21, 2006, states:

--Medicare's national coverage of bariatric surgery will be expanded for all Medicare beneficiaries. For seniors over age 65, who have experienced high complication rates in some settings, Medicare will cover the procedure only in high-volume centers that achieve low mortality rates and are certified by the American College of Surgeons and the American Society for Bariatric Surgery.

--The list of nationally-covered procedures now includes open and laparoscopic Roux-en-Y gastric bypass, laparoscopic adjustable gastric banding, and open and laparoscopic biliopancreatic diversion with duodenal switch. Prior to yesterday's decision, CMS' only nationally-covered bariatric surgery procedure was gastric bypass surgery.

"We are very pleased with CMS' decision to cover bariatric services for all Medicare beneficiaries via a comprehensive programmatic approach. We believe this coverage will not only save costs which are normally associated with health problems caused by obesity but will also save lives and alleviate substantial disability and suffering," stated Michael Owens, President and CEO of iVOW. "We see this CMS ruling as a forerunner of broader commercial payor coverage of these procedures and look forward to demonstrating to payors, providers and employers our enhanced value proposition consequent to this ruling. We believe this is a crucial step in healthcare organizations and insurers firmly and definitively embracing the positive impact of a comprehensive, programmatic approach to the treatment of chronic and morbid obesity. iVOW has consistently articulated the value of this approach and our business model is significantly predicated upon providing collaborative outsourced services to our clients to facilitate the ease of operation and quality of such programs."

About iVOW, Inc.

Our business is focused exclusively on the disease state management of chronic and morbid obesity. We provide program management, healthcare services, operational consulting and clinical training services to employers, payors, physicians and hospitals involved in the medical and surgical treatment of the chronic a morbidly obese. We also provide specialized vitamins to patients who have undergone obesity surgery. Our corporate website is www.ivow.com; information on our nutritional supplements for post-surgical gastric bypass patients may be found on www.vistavitamins.com. iVOW is the new corporate name of Vista Medical Technologies, Inc. iVOW is traded on the NASDAQ Capital Market under the stock symbol IVOW.

Forward Looking Statements

This news release may contain forward-looking statements concerning the business and products of iVOW, Inc. Actual results may differ materially depending on a number of risk factors, including, but not limited to the following: the Company's ability to raise additional funds to support its operations; the Company's ability to penetrate the market for obesity surgery management services; the final decision by CMS on coverage for bariatric surgery, the Company's ability to raise additional funds to support its business plan and the Company's ability to successfully integrate the business and operations of Sound Health Solutions, Inc. Other risks inherent in our business are described in the Company's Securities and Exchange Commission filings, including its Quarterly Report on Form 10-QSB for the nine-month period ended September 30, 2005. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.